Sales Expansion

Quote










































Some advice for “those of you who are used to your fifth payout”:

Don’t do it. I fell for the big pay and the Braeburn vision too and then ended up with nothing. You think you are miserable at Indivior because of what? They don’t have anywhere NEAR the problems of big pharma and they are not a startup, a hybrid of a company that these biotechs are striving to be! Take a look at the success rate for start ups in the past 10 years and decide if it’s really worth it to take this risk. Big pay=Big risk
 






anonymous said:
Some advice for “those of you who are used to your fifth payout”:

Don’t do it. I fell for the big pay and the Braeburn vision too and then ended up with nothing. You think you are miserable at Indivior because of what? They don’t have anywhere NEAR the problems of big pharma and they are not a startup, a hybrid of a company that these biotechs are striving to be! Take a look at the success rate for start ups in the past 10 years and decide if it’s really worth it to take this risk. Big pay=Big risk
Click to expand...

Judging by the comments on their board, one would think it's the worst company out there. But go to any pharma company board and you'll see the exact same bitching. I didn't jump for this company bc they have a shitty track record in the short time they've been around, and they're nowhere near as financially solvent as Indivior is. Have they EVER turned a profit? Indivior already has the jump on them, with a product that appears clinically superior, at least on paper. CAM's doses are low for the monthly, and a weekly injectable seems like more trouble than it's worth for offices. Some went for the payday, and I have a feeling they'll regret it. Indivior, for all its faults, still has over a decade of experience in this market and did their homework with their new injectable. As AP stated, Indivior isn't big pharma in terms of overhead and staff so they can absorb some revenue loss without slashing sales force. And they're in a much better financial position than Braeburn. This isn't an Indivior homer talking, but someone who is looking at both companies as objectively as possible. And you can't discount the brand recognition either, naming their product something similar to Suboxone will help. Managed care will determine a lot, but again I don't trust a start up over a company with years of relationships in this area.
 






anonymous said:
Judging by the comments on their board, one would think it's the worst company out there. But go to any pharma company board and you'll see the exact same bitching. I didn't jump for this company bc they have a shitty track record in the short time they've been around, and they're nowhere near as financially solvent as Indivior is. Have they EVER turned a profit? Indivior already has the jump on them, with a product that appears clinically superior, at least on paper. CAM's doses are low for the monthly, and a weekly injectable seems like more trouble than it's worth for offices. Some went for the payday, and I have a feeling they'll regret it. Indivior, for all its faults, still has over a decade of experience in this market and did their homework with their new injectable. As AP stated, Indivior isn't big pharma in terms of overhead and staff so they can absorb some revenue loss without slashing sales force. And they're in a much better financial position than Braeburn. This isn't an Indivior homer talking, but someone who is looking at both companies as objectively as possible. And you can't discount the brand recognition either, naming their product something similar to Suboxone will help. Managed care will determine a lot, but again I don't trust a start up over a company with years of relationships in this area.
Click to expand...
 


















There will be plenty to leave but none that will be missed. When u chase a little money in the short term u lose in the long run. This company has yet to have a month making money. How long until the money runs out. There’s no evidence they are even going to get approval. Just too much risk for an unproven company. And their hiring tactics were so grimy and underhanded. They made it obvious they were little brother and they knew it. They are trying to over pay for relationships they don’t have but how long can they do that? Bad business
 






company is taking cheap way out! They don't want to pay good reps but will try to retread old ones or buy what they think are ones with relationship. Trust me call the ones w/buy and bill experience and it will be a better decision than the direction we've turned. Let's stop being 2nd rate and make necessary changes to succeed!
 










































Top Bottom
Back
Quote